Signal #144471 · SEC 8-K

$COLL SEC Filing Alert & Real-Time AI Stock Impact Analysis

Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).

FAQ: $COLL filing catalyst

Why did $COLL trigger an AI stock catalyst alert?

$COLL triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: -2.5/10). Headline: Collegium Q3 Net Revenue Up 3% to $216.3M, Diluted EPS Declines to $0.60; Reaffirms 2026 Guidance. Key points: - Net revenue rose 3% YoY to $216.3M, driven by JORNAY PM ($51.9M) and AZSTARYS ($26.5M). - Net income declined 31% YoY to $21.8M with diluted EPS falling from $0.84 to $0.60; Adj. EBITDA down to $121.6M vs $133.0M. - Reaffirmed FY2026 revenue guidance of $825M–$855M and Adjusted EBITDA of $445M–$470M.

How did $COLL stock react after the SEC filing?

After the SEC 8-K for $COLL, observed market reaction: T0 price $23.67. Past moves do not guarantee future results.

Where can I get real-time $COLL SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $COLL via Telegram and the VIP Web Terminal from €10/month.

$COLL

$COLL – Collegium Q3 Net Revenue Up 3% to $216.3M, Diluted EPS Declines to $0.60; Reaffirms 2026 Guidance

COLLEGIUM PHARMACEUTICAL, INC

2026-11-05 00:00:00 UTC · SEC 8-K · All $COLL

Unlocked archive · Analyzed in <2s at T0

Bearish AI Sentiment (-2.5 / 10)

Net revenue rose 3% YoY to $216.3M, driven by JORNAY PM ($51.9M) and AZSTARYS ($26.5M).
Net income declined 31% YoY to $21.8M with diluted EPS falling from $0.84 to $0.60; Adj. EBITDA down to $121.6M vs $133.0M.
Reaffirmed FY2026 revenue guidance of $825M–$855M and Adjusted EBITDA of $445M–$470M.

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →